Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Repurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritis

JCI Insight(2023)10.1172/jci.insight.165024Source: DataRank Database

Repurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritis is a research paper published in JCI Insight (2023). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 1.10)OA: goldTopics (52)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Fani Roumelioti,Christos Tzaferis ORCID,Panagiotis Chouvardas ORCID,Anna-Kathrine Pedersen ORCID,Filippos Charalampous

Live enrichment

PubMed:37014697 OpenAlex:https://openalex.org/W4362523157

European Commission

Grant: 101055093

Contextual specification of fibroblast-driven causalities in chronic intestinal inflammation and fibrosis

European Commission

Grant: 823839

European Proteomics Infrastructure Consortium providing Access

FWCI

1.10

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttp://insight.jci.org/articles/view/165024/files/pdf

publisherhttp://insight.jci.org/articles/view/165024/files/pdf

publisherhttps://insight.jci.org/articles/view/165024/files/pdf

journalhttps://doi.org/10.1172/jci.insight.165024

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37014697

Fields of Study

Protein Degradation and InhibitorsTryptophan and brain disordersToxin Mechanisms and Immunotoxins03 medical and health sciences0302 clinical medicineAnimalsHumansSynovial MembraneAntipsychotic AgentsAmisulprideDrug RepositioningArthritis, RheumatoidFibroblastsDNA Helicases

MeSH Terms

AmisulprideAnimalsArthritis, RheumatoidDNA HelicasesFibroblastsHumansSynovial MembraneAntipsychotic AgentsDrug Repositioning

Keywords

AmisulprideDrug repositioningMedicinePharmacologyTumor necrosis factor alphaArthritisAntipsychoticDrugImmunologySchizophrenia (object-oriented programming)PsychiatryFibroblasts/metabolismSynovial MembraneRDNA HelicasesTherapeuticsFibroblastsSynovial Membrane/metabolismDNA Helicases/metabolismAntipsychotic Agents/pharmacologyArthritis, RheumatoidArthritis, Rheumatoid/metabolismAmisulpride/pharmacologyRheumatoid/metabolismAnimalsHumansResearch ArticleAntipsychotic AgentsMouse models

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being